PD Theranostics, Inc. — Form D
PD Theranostics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2023-12-14. The offering totals $1.0M, of which $150K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-12-14
- Form: D
- Accession: 0001493152-23-044874
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $150K
- Remaining: $850K
- Investors: 2
- Date of first sale: 2022-07-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-499738
Issuer
- Name: PD Theranostics, Inc.
- CIK: 0001830286
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 12 E 49TH STREET, NEW YORK, NY, 10017
- Phone: 646-335-5923
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| James Ahern | Director | New York, NY |
| Matthew Duffy | Director | New York, NY |
| Matthew Eitner | Director | New York, NY |
| Patrick Gallagher | Director | Charlotte, NC |
| Matthew Duffy | Executive Officer | New York, NY |
| Patrick Gallagher | Executive Officer | Charlotte, NC |
Other filings by this issuer (2)
More